Testosterone 87 — Class II drug recall D-0237-2019
Terminated recall by Qualgen, LLC, reported 2018-11-14, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0237-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Qualgen, LLC, Edmond, OK, United States |
| Recall initiated | 2018-10-17 |
| Classified | 2018-11-07 |
| Reported by FDA | 2018-11-14 |
| Terminated | 2020-06-04 |
| Distributed | Nationwide (US) |
| Reason classes | sterility |
| NDC | 69761-0187-01, 69761-0187-06, 69761-0187-12, 69761-0187-30 |
| Lot numbers | C243, D010, D025 |
| Expiration dates | 2018-11-21, 2019-01-11, 2019-01-30 |
Product
Testosterone 87.5mg pellet, 1 count (NDC 69761-187-01), 6 count (NDC 69761-187-06), 12 count (NDC 69761-187-12), and 30 count (NDC 69761-187-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0237-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.